Novo Nordisk have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended marketing authorisation for Awiqli for treatment of diabetes in adults.
Madrigal Pharmaceuticals have announced that the U.S. FDA has granted accelerated approval for Rezdiffra (resmetirom) in conjunction with diet and exercise for the treatment of adults with noncirrhotic NASH.
Biocon Biologics Limited have announced a long -term commercial collaboration with Eris Lifesciences to expand patient access to its portfolio of Metabolics, Oncology, and Critical Care products in India.
Speaking at an event in Edinburgh, Chris Dougray, Head of Development at CBRE Scotland, and Chris Williams, CBRE’s Head of Life Sciences, joined forces to examine the burgeoning sector’s place in Scotland.
We hear from Don Riach, UK Operations Director at Biocair, who explores approaches to safe and sustainable delivery and next generation packaging for the life sciences sector.
Sandoz have entered into a settlement agreement with the class of direct purchaser plaintiffs in the multidistrict litigation entitled In re Generic Pharmaceuticals Pricing Antitrust Litigation.
Dalip Sethi, Ph.D. and Joy Duemke, at Terumo Blood and Cell Technologies explore how automated apheresis platforms function as a therapeutic and an enabling technology for cell-based therapies.
